U S Physical Therapy Inc Revenue Growth Rates (USPH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
U S Physical Therapy Inc  (NYSE: USPH)
 

USPH's Revenue Growth by Quarter and Year

U S Physical Therapy Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

USPH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 214.06
1st Quarter March 198.29
FY 412.35

USPHs Annual Revenue
U S Physical Therapy Inc's Revenue in the fiscal year 2025 $ 780.99 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2024 $ 671.35 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2023 $ 604.80 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2022 $ 112.02 millions
U S Physical Therapy Inc's Revenue in the fiscal year 2021 $ 495.02 millions




USPH Revenue second quarter 2026 Y/Y Growth Comment
U S Physical Therapy Inc reported Revenue growth of 8.47% year on year in the second quarter 2026, to $ 214.06 millions, this is lower than U S Physical Therapy Inc's recent average Revenue increase of 14.25%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 108 other companies have achieved higher Revenue growth. While U S Physical Therapy Inc' s Revenue increase of 8.47% ranks overall at the positon no. 2035 in the second quarter 2026.


USPH Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 12.35 % 16.57 % 9.65 %
3rd Quarter September - 17.32 % 12.01 % 460.16 %
2nd Quarter June 8.47 % 18.03 % 10.36 % 7.7 %
1st Quarter March 7.89 % 18.06 % 404.47 % -76.57 %
FY   - 16.33 % 37.81 % -

Financial Statements
U S Physical Therapy Inc's second quarter 2026 Revenue $ 214.06 millions USPH's Income Statement
U S Physical Therapy Inc's second quarter 2025 Revenue $ 197.34 millions Quarterly USPH's Income Statement


USPH Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 2.84 % 7.39 % 3.19 %
3rd Quarter September - -0.11 % 0.5 % -0.98 %
2nd Quarter June 7.95 % 7.37 % 7.39 % 390.89 %
1st Quarter March -2.19 % 1.85 % 0.57 % -78.14 %
FY (Year on Year)   - 16.33 % 37.81 % -


Back to USPH Growth rate Comparisons >> Back to USPH Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #109
Healthcare Sector #304
Overall #2035

Revenue Y/Y Growth Statistics
High Average Low
176.11 % 14.25 % -56.04 %
(Jun 30 2024)   (Mar 31 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #109
Healthcare Sector #304
Overall #2035
Revenue Y/Y Growth Statistics
High Average Low
176.11 % 14.25 % -56.04 %
(Jun 30 2024)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

U S Physical Therapy Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
427.11 % 12.86 % -80.96 %
(Dec 31 2022)  


USPH's II. Quarter Q/Q Revenue Comment
U S Physical Therapy Inc achieved in the II. Quarter 2026 below company average Revenue increase of 7.95% quarter on quarter, to $ 214.06 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 7.37% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While U S Physical Therapy Inc's Revenue growth quarter on quarter, overall rank is 906.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #141
Overall #906
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #141
Overall #906
Revenue Q/Q Growth Statistics
High Average Low
427.11 % 12.86 % -80.96 %
(Dec 31 2022)  


USPH's II. Quarter Q/Q Revenue Comment
U S Physical Therapy Inc achieved in the II. Quarter 2026 below company average Revenue increase of 7.95% quarter on quarter, to $ 214.06 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 7.37% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While U S Physical Therapy Inc's Revenue growth quarter on quarter, overall rank is 906.


U S Physical Therapy Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 812.20 $ 795.49 $ 780.99 $ 758.71 $ 729.61
Y / Y Revenue Growth (TTM) 11.32 % 13.73 % 16.33 % 17.5 % 16.24 %
Year on Year Revenue Growth Overall Ranking # 814 # 274 # 39 # 36 # 64
Seqeuential Revenue Change (TTM) 2.1 % 1.86 % 2.94 % 3.99 % 4.31 %
Seq. Revenue Growth (TTM) Overall Ranking # 2035 # 1833 # 889 # 1351 # 392


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, U S Physical Therapy Inc's cumulative twelve months Revenue were $ 812 millions, company would post below average annual Revenue growth of 4.31% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the U S Physical Therapy Inc's Revenue growth from the 198.29% growth in Mar 31 2026.

In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 274 to 814.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 174
Overall # 814

Revenue TTM Y/Y Growth Statistics
High Average Low
176.11 %
 14.25 %
-56.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 304
S&P 500 # 2035
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, U S Physical Therapy Inc's cumulative twelve months Revenue were $ 812 millions, company would post below average annual Revenue growth of -56.04% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the U S Physical Therapy Inc's Revenue growth from the 198.29% growth in Mar 31 2026.

In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 274 to 814.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 174
Overall # 814

Revenue TTM Y/Y Growth Statistics
High Average Low
176.11 %
14.25 %
-56.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 304
S&P 500 # 2035




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
USPH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Rockwell Medical inc 14.69%$ 14.687 millions
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions


About U S Physical Therapy Inc Revenue Growth Rates (USPH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: U S Physical Therapy Inc Nv (CIK 885978).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001140361-26-031825
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: U S Physical Therapy Inc Nv’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.